Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
128 hedge funds and large institutions have $678M invested in Intersect ENT, Inc in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 9 closing their positions.
244% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 9
98% more call options, than puts
Call options by funds: $4.47M | Put options by funds: $2.26M
86% more capital invested
Capital invested by funds: $365M → $678M (+$313M)
21% more funds holding
Funds holding: 106 → 128 (+22)
2% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 41
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$26.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.9M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$20.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$7.6M |
| 5 |
BlackRock
New York
|
+$6.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.06M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$8.92M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.68M |
| 4 |
Morgan Stanley
New York
|
-$6.64M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$5.13M |
XENT Hedge Fund Activity: Q2 2017 in Review
128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2017, worth a combined $678M — up 86% from $365M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new XENT positions and 9 closed out — a net gain of 22 holders — while 42 added to existing stakes and 41 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $26.9M. The largest seller was Adage Capital Partners, cutting an estimated $9.06M.
- 128 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2017, up from 106 in Q1 2017.
- Funds reported $678M of Intersect ENT, Inc stock for Q2 2017, up 86% quarter-over-quarter.
- 31 funds opened new Intersect ENT, Inc positions in Q2 2017 and 9 closed out, a net change of +22 holders.
- The largest Intersect ENT, Inc buyer in Q2 2017 was Deerfield Management, an estimated $26.9M added.
- The largest Intersect ENT, Inc seller in Q2 2017 was Adage Capital Partners, an estimated $9.06M sold.
Based on aggregated 13F filings for Q2 2017.